Cargando…

Prevalence of the Antiphospholipid Syndrome and Its Effect on Survival in 679 Chinese Patients With Systemic Lupus Erythematosus: A Cohort Study

In this work we evaluate the prevalence of the antiphospholipid syndrome (APS) and its impact on survival in Chinese patients with systemic lupus erythematosus (SLE). We studied a prospective cohort of southern Chinese patients who fulfilled ≥4 American College of Rheumatology criteria for SLE. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mok, Chi Chiu, Chan, Pak To, Ho, Ling Yin, Yu, Ka Lung, To, Chi Hung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2013
Materias:	Original Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553973/ https://www.ncbi.nlm.nih.gov/pubmed/23793109 http://dx.doi.org/10.1097/MD.0b013e31829cae47

Ejemplares similares

Trend of Survival of a Cohort of Chinese Patients With Systemic Lupus Erythematosus Over 25 Years
por: Mok, Chi Chiu, et al.
Publicado: (2020)

ITGAM is associated with disease susceptibility and renal nephritis of systemic lupus erythematosus in Hong Kong Chinese and Thai
por: Yang, Wanling, et al.
Publicado: (2009)

Validation of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in ANA-positive Chinese patients
por: Chung, Yuen Kwan, et al.
Publicado: (2022)

Rationale and design of the screening of pulmonary hypertension in systemic lupus erythematosus (SOPHIE) study
por: Huang, Duo, et al.
Publicado: (2018)

The Dawn of a New Era of Therapies in Systemic Lupus Erythematosus
por: Mok, Chi Chiu
Publicado: (2020)

Targeted Small Molecules for Systemic Lupus Erythematosus: Drugs in the Pipeline
por: Mok, Chi Chiu
Publicado: (2023)

IgA Antiphospholipid Antibodies in Antiphospholipid Syndrome and Systemic Lupus Erythematosus
por: Reshetnyak, Tatiana, et al.
Publicado: (2022)

Editorial: Systemic Lupus Erythematosus and Antiphospholipid Syndrome
por: Meroni, Pier Luigi, et al.
Publicado: (2019)

Estimation of fracture risk by the FRAX tool in patients with systemic lupus erythematosus: a 10-year longitudinal validation study
por: Mok, Chi Chiu, et al.
Publicado: (2022)

The Coexistence of Antiphospholipid Syndrome and Systemic Lupus Erythematosus in Colombians
por: Franco, Juan-Sebastian, et al.
Publicado: (2014)

Coexistence of pituitary macroadenoma with systemic lupus erythematosus and antiphospholipid syndrome
por: Valizadeh, Neda, et al.
Publicado: (2012)

Neutrophils—Important Communicators in Systemic Lupus Erythematosus and Antiphospholipid Syndrome
por: Wirestam, Lina, et al.
Publicado: (2019)

Markers of NETosis in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome
por: Reshetnyak, Tatiana, et al.
Publicado: (2023)

Hesitancy for SARS-CoV-2 vaccines and post-vaccination flares in patients with systemic lupus erythematosus
por: Mok, Chi Chiu, et al.
Publicado: (2022)

Pulmonary manifestations of systemic lupus erythematosus patients with and without antiphospholipid syndrome
por: Hamdani, Muhammad Afzal, et al.
Publicado: (2015)

Corticobasal Syndrome Associated with Antiphospholipid Syndrome Secondary to Systemic Lupus Erythematosus
por: Hashimoto, Ritsuo, et al.
Publicado: (2018)

Tumid lupus erythematosus–like pseudovasculitic lesions in catastrophic antiphospholipid syndrome
por: Wang, Jenny Z., et al.
Publicado: (2019)

Association of Antiphospholipid Antibodies with Clinical Manifestations in Children with Systemic Lupus Erythematosus
por: Petrovic, Gordana, et al.
Publicado: (2023)

An Antiphospholipid Antibody Profile as a Biomarker for Thrombophilia in Systemic Lupus Erythematosus
por: Hisada, Ryo, et al.
Publicado: (2023)

Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL)
por: Savelli, Stephanie L., et al.
Publicado: (2019)

Transverse myelitis: a complication of systemic lupus erythematosus that is associated with the antiphospholipid syndrome.
por: Smyth, A. E., et al.
Publicado: (1996)

‘Atherothrombosis-associated microRNAs in Antiphospholipid syndrome and Systemic Lupus Erythematosus patients’
por: Pérez-Sánchez, C., et al.
Publicado: (2016)

Libman-Sacks endocarditis in patients with systemic lupus erythematosus with secondary antiphospholipid syndrome
por: Mohammadi Kebar, Yousef, et al.
Publicado: (2019)

Insights into the Procoagulant Profile of Patients with Systemic Lupus Erythematosus without Antiphospholipid Antibodies
por: Monzón Manzano, Elena, et al.
Publicado: (2020)

Severe thrombotic complications secondary to antiphospholipid syndrome and undiagnosed systemic lupus erythematosus
por: Barber, Megan R.W., et al.
Publicado: (2022)

Early Prediction of Adverse Pregnancy Outcome in Women with Systemic Lupus Erythematosus, Antiphospholipid Syndrome, or Non-Criteria Obstetric Antiphospholipid Syndrome
por: Baños, Núria, et al.
Publicado: (2022)

Thrombolytic Therapy for Cerebral Vein Thrombosis in Antiphospholipid Syndrome Secondary to Systemic Lupus Erythematosus
por: Hajialilo, Mehrzad, et al.
Publicado: (2012)

Antiglutamate Receptor Antibodies and Cognitive Impairment in Primary Antiphospholipid Syndrome and Systemic Lupus Erythematosus
por: Gerosa, Maria, et al.
Publicado: (2016)

Clinical implications of systemic lupus erythematosus without and with antiphospholipid syndrome in peri- and postmenopausal age
por: Grygiel-Górniak, Bogna, et al.
Publicado: (2018)

Systemic lupus erythematosus with antiphospholipid syndrome: Cardiovascular magnetic resonance for evaluation of cardiac hypertrophy
por: Mavrogeni, Sophie I., et al.
Publicado: (2017)

Effectiveness of a multidisciplinary clinical pathway for women with systemic lupus erythematosus and/or antiphospholipid syndrome
por: Wind, Merlijn, et al.
Publicado: (2021)

Platelets and the Lectin Pathway of Complement Activation in Patients with Systemic Lupus Erythematosus or Antiphospholipid Syndrome
por: Vils, Signe Risbøl, et al.
Publicado: (2023)

Systemic Lupus Erythematosus and Antiphospholipid Syndrome Accompanied by Mixed-Type Autoimmune Hemolytic Anemia
por: Suzuki, Eiji, et al.
Publicado: (2023)

The Role of Neutrophil Extracellular Traps (NETs) in the Pathogenesis of Systemic Lupus Erythematosus and Antiphospholipid Syndrome
por: Reshetnyak, Tatiana, et al.
Publicado: (2023)

Antiphospholipid antibody positivity in early systemic lupus erythematosus is associated with subsequent vascular events
por: Farina, Nicola, et al.
Publicado: (2022)

Childhood-Onset Systemic Lupus Erythematosus Presenting With Concomitant Gastrointestinal Manifestation and Antiphospholipid Syndrome
por: Mohd Shukri, Nur Diyana, et al.
Publicado: (2023)

Bilateral Retinal Vasculitis as Initial Presentation of Systemic Lupus Erythematosus with Secondary Antiphospholipid Syndrome
por: Aldhefeery, Nora, et al.
Publicado: (2023)

FRI679 Risks Of Incident Major Osteoporotic Fractures Following SARS-CoV-2 Infection
por: Lui, David, et al.
Publicado: (2023)

Systemic Lupus Erythematosus and Immunodeficiency
por: Chan, Shirley Chiu Wai, et al.
Publicado: (2021)

Interleukin-33 Ameliorates Murine Systemic Lupus Erythematosus and Is Associated with Induction of M2 Macrophage Polarisation and Regulatory T Cells
por: Mok, Mo Yin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_91uubfkd6c9ph4dl08gapfdobh